Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI

Magnetic Resonance in Medicine

Volumn 53, Issue 4, 2005, Pages 830-834

  Aime, Silvio ^c,d   Calabi, Luisella ^a   Biondi, Luca ^a   De Miranda, Mario ^a   Ghelli, Stefano ^b   Paleari, Lino ^a   Rebaudengo, Cristina ^a   Terreno, Enzo ^c,d  

^a Bracco Imaging SpA   (Italy)

^b Spinlab   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Molecular Imaging Center   (Italy)

Author keywords

CEST; Contrast agents; Iopamidol; MRI; T2 agent

Indexed keywords

AMIDES; MAGNETIC RESONANCE IMAGING;

CEST; CHEMICAL EXCHANGE SATURATION TRANSFER; CLINICAL PROTOCOLS; CONTRAST AGENT; DIAGNOSTIC APPLICATIONS; IOPAMIDOL; IRRADIATION FIELDS; X-RAY CONTRAST AGENTS;

CONTRAST MEDIA;

CONTRAST MEDIUM; IOPAMIDOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTON;

ARTICLE; CHEMICAL EXCHANGE SATURATION TRANSFER; CONTRAST ENHANCEMENT; DRUG SOLUBILITY; HUMAN; MATHEMATICAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; RADIOFREQUENCY;

EID: 16444378910     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20441     Document Type: Article

References (19)

1. Pitrè D, Felder E. Development, chemistry and physical properties of iopamidol and its analogues. Invest Radiol 1980;15:301-309.
2. McKinstry DN, Rommel AJ, Sugerman AA. Pharmacokinetics, metabolism and excretion of iopamidol in healthy subjects. Invest Radiol 1984;19:171-174.
3. Dawson P, Bradshaw A, Hill C. Jopamiron: a new non-ionic contrast medium. Acta Radiol Diagn 1984;25:253-256.
4. Mutzel W, Speck U. Tolerance and biochemical pharmacology of Jopamiron. Rofo 1983;118-125.
5. Bourin M, Jolliet P, Ballereau F. An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet 1997;32:180-193.
6. 2 by chemical exchange. Invest Radiol 1888;23(Suppl 1):S267-S270.
7. Aime S, Botta M, Barbero L, Uggeri F, Fedeli F. Water signal suppression by T2-relaxation enhancement promoted by dysprosium(III) complexes. Magn Reson Chem 1991;29:S85-S88.
8. Muller RN, Bulte JVM, Gillis P, Roch A, Laurent S, Botteman F, Vander Elst L. Impact of water exchange kinetics on the transverse relaxivity of some Dy-DTPA derivatives, potential negative contrast agents for high field imaging. MAGMA 1999;8:S13-S14.
9. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79-87.
10. Swift TJ, Connick RE. NMR-relaxation mechanism of O-17 in aqueous solutions of paramagnetic cations and the lifetime of water molecules in the first coordination sphere. J Chem Phys 1962;37:307.
11. Goffeney N, Bulte JVM, Duyn J, Bryant Jr LH, van Zijl PCM. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc 2001;123:8628-8629.
12. Zhang S, Michaudet L, Burgess S, Sherry AD. The amide protons of a ytterbium(III)-DOTA-tetraamide complex act as efficient antennae for transfer of magnetization to bulk water. Angew Chem Int Ed 2002;41:1919-1921.
13. Aime S, Delli Castelli D, Terreno E. Novel pH-reporter MRI contrast agents. Angew Chem Int Ed 2002;41:4334-4336.
14. Zhang S, Merritt M, Woessner DE. PARACEST agents: modulating MRI contrast via water proton exchange. Acc Chem Res 2003;36:783-790.
15. Aime S, Delli Castelli D, Terreno E. Supramolecular adducts between poly-L-arginine and Tm(III)DOTP: a route to sensitivity enhanced MRI-CEST contrast agents. Angew Chem Int Ed 2003;42:4527-4529.
16. Terreno E, Delli Castelli D, Cravotto G, Milone L, Aime S. Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest Radiol 2004;39:235-243.
17. Forsen S, Hoffman RA. Study of the moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963;39:2892-2901.
18. 31P magnetization transfer studies of hindleg muscle in wild-type and creatine kinase-deficient mice. Magn Reson Med 2000;43:657-664.
19. Snoussi K, Bulte JWM, Guéron M, van Zijl PCM. Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med 2003;49:998-1005.